Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 3
1994 1
1995 10
1996 4
1998 2
1999 2
2000 1
2001 1
2002 1
2003 2
2005 2
2007 2
2008 2
2009 6
2010 5
2011 4
2012 6
2013 4
2014 3
2015 8
2016 4
2017 4
2018 2
2019 3
2020 7
2021 5
2022 9
2023 7
2024 8
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer.
Kortleve D, Hammerl D, van Brakel M, Wijers R, Roelofs D, Kroese K, Timmermans MM, Liao CY, Huang S, Trapman-Jansen A, Foekens R, Michaux J, de Beijer MTA, Buschow SI, Demmers JAA, Kok M, Danen EHJ, Bassani-Sternberg M, Martens JWM, Abbott RJM, Debets R. Kortleve D, et al. Among authors: danen ehj. Cancer Discov. 2024 Dec 2;14(12):2450-2470. doi: 10.1158/2159-8290.CD-24-0168. Cancer Discov. 2024. PMID: 39172012 Free PMC article.
Targeting ABC transporters in PDAC - past, present, or future?
Bergonzini C, Giovannetti E, Danen EHJ. Bergonzini C, et al. Among authors: danen ehj. Oncotarget. 2024 Jun 20;15:403-406. doi: 10.18632/oncotarget.28597. Oncotarget. 2024. PMID: 38900606 Free PMC article. No abstract available.
Targeted radiosensitization in prostate cancer.
Ghotra VP, Geldof AA, Danen EH. Ghotra VP, et al. Among authors: danen eh. Curr Pharm Des. 2013;19(15):2819-28. doi: 10.2174/1381612811319150017. Curr Pharm Des. 2013. PMID: 23448469 Review.
A guide to mechanobiology: Where biology and physics meet.
Jansen KA, Donato DM, Balcioglu HE, Schmidt T, Danen EH, Koenderink GH. Jansen KA, et al. Among authors: danen eh. Biochim Biophys Acta. 2015 Nov;1853(11 Pt B):3043-52. doi: 10.1016/j.bbamcr.2015.05.007. Epub 2015 May 18. Biochim Biophys Acta. 2015. PMID: 25997671 Free article. Review.
GRHL2-controlled gene expression networks in luminal breast cancer.
Wang Z, Coban B, Wu H, Chouaref J, Daxinger L, Paulsen MT, Ljungman M, Smid M, Martens JWM, Danen EHJ. Wang Z, et al. Among authors: danen ehj. Cell Commun Signal. 2023 Jan 23;21(1):15. doi: 10.1186/s12964-022-01029-5. Cell Commun Signal. 2023. PMID: 36691073 Free PMC article.
Fibronectin, integrins, and growth control.
Danen EH, Yamada KM. Danen EH, et al. J Cell Physiol. 2001 Oct;189(1):1-13. doi: 10.1002/jcp.1137. J Cell Physiol. 2001. PMID: 11573199 Review.
ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells.
Bergonzini C, Gregori A, Hagens TMS, van der Noord VE, van de Water B, Zweemer AJM, Coban B, Capula M, Mantini G, Botto A, Finamore F, Garajova I, McDonnell LA, Schmidt T, Giovannetti E, Danen EHJ. Bergonzini C, et al. Among authors: danen ehj. J Exp Clin Cancer Res. 2024 Jan 2;43(1):4. doi: 10.1186/s13046-023-02879-8. J Exp Clin Cancer Res. 2024. PMID: 38163893 Free PMC article.
111 results